Future Science Group's Therapeutic Delivery journal is to reach a wider audience after being selected for coverage by the Chemical Abstracts Service (CAS).
The American Chemical Society-run body is considered one of the most authoritative sources for chemical information, operating reputable databases such as CAS Registry.
Therapeutic Delivery is published monthly and focuses on the combination of technological, pharmacological, clinical and physiological aspects of modern therapeutics.
Future Science Group stated that it will be taking steps with its associate editors to ensure that the quality of the publication justifies its inclusion, such as making sure that the journal is up to date with the latest developments in the field.
Elisa Manzotti, editorial director of the Future Science series, said: "We would like to thank our editorial board for their hard work, intellectual input and guidance in targeting and evaluating topical, pioneering content."
This comes after another Future Science Group publication, Clinical Investigation, was also accepted for Chemical Abstracts coverage earlier this month.